ZEOX (Zeo ScientifiX) Inventory-to-Revenue : 0.24 (As of Jul. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Zeo ScientifiX Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Zeo ScientifiX's Average Total Inventories for the quarter that ended in Jul. 2024 was $0.26 Mil. Zeo ScientifiX's Revenue for the three months ended in Jul. 2024 was $1.09 Mil. Zeo ScientifiX's Inventory-to-Revenue for the quarter that ended in Jul. 2024 was 0.24.

Zeo ScientifiX's Inventory-to-Revenue for the quarter that ended in Jul. 2024 declined from Apr. 2024 (0.26) to Apr. 2024 (0.24)

A decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Zeo ScientifiX's Days Inventory for the three months ended in Jul. 2024 was 135.32.

Inventory Turnover measures how fast the company turns over its inventory within a year. Zeo ScientifiX's Inventory Turnover for the quarter that ended in Jul. 2024 was 0.67.

Zeo ScientifiX Inventory-to-Revenue Historical Data

The historical data trend for Zeo ScientifiX's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zeo ScientifiX Inventory-to-Revenue Chart

Zeo ScientifiX Annual Data

Trend

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Inventory-to-Revenue

Get a 7-Day Free Trial

0.05

0.04

0.03

0.04

0.06

Zeo ScientifiX Quarterly Data
	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24
Inventory-to-Revenue	Get a 7-Day Free Trial															0.21	0.20	0.27	0.26	0.24

Competitive Comparison of Zeo ScientifiX's Inventory-to-Revenue

For the Biotechnology subindustry, Zeo ScientifiX's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zeo ScientifiX's Inventory-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zeo ScientifiX's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Zeo ScientifiX's Inventory-to-Revenue falls into.

Zeo ScientifiX Inventory-to-Revenue Calculation

Zeo ScientifiX's Inventory-to-Revenue for the fiscal year that ended in Oct. 2023 is calculated as

	Inventory-to-Revenue (A: Oct. 2023 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (A: Oct. 2022 )	+	Total Inventories (A: Oct. 2023 ))	/	count )	/	Revenue (A: Oct. 2023 )
=	( (0.249	+	0.31)	/	2 )	/	4.558
=	0.2795					/	4.558
=	0.06

Zeo ScientifiX's Inventory-to-Revenue for the quarter that ended in Jul. 2024 is calculated as

	Inventory-to-Revenue (Q: Jul. 2024 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (Q: Apr. 2024 )	+	Total Inventories (Q: Jul. 2024 ))	/	count )	/	Revenue (Q: Jul. 2024 )
=	( (0.272	+	0.25)	/	2 )	/	1.091
=	0.261					/	1.091
=	0.24

Zeo ScientifiX (OTCPK:ZEOX) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Zeo ScientifiX's Days Inventory for the three months ended in Jul. 2024 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Jul. 2024 )	/	Cost of Goods Sold (Q: Jul. 2024 )	*	Days in Period
	=	0.261	/	0.176	*	365 / 4
	=	135.32

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Zeo ScientifiX's Inventory Turnover for the quarter that ended in Jul. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Jul. 2024 )	/	Average Total Inventories (Q: Jul. 2024 )
	=	0.176	/	0.261
	=	0.67

Zeo ScientifiX Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Zeo ScientifiX's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Zeo ScientifiX Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zeo ScientifiX Inc (OTCPK:ZEOX) » Definitions » Inventory-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

3321 College Avenue, Suite 246, Davie, FL, USA, 33314

Website

https://www.organicell.com

Zeo ScientifiX Inc is a clinical-stage biopharmaceutical company located inside Nova Southeastern University's Collaborative Center for Research in Davie, Florida. It is principally focusing on the development of innovative biological therapeutics for the treatment of chronic diseases and the provision of related services.

Executives

Skycrest Holdings, Llc	10 percent owner	1930 HARRISON STREET, SUITE 204, HOLLYWOOD FL 33020
Harry L. Leider	director, officer: CEO and Director	C/O GELESIS, INC., 501 BOYLSTON STREET, SUITE 6102, BOSTON MA 02116
Howard Lawrence Golub	officer: Executive Vice President & CSO	23648 SEPTEMBER SUN SQ, ASHBURN VA 20148
Matthew Phillip Sinnreich	officer: COO and Acting CEO	4045 SHERIDAN AVENUE, SUITE 239, MIAMI BEACH FL 33139
Steven Jerry Glauser	director	1428 BRICKELL AVENUE, SUITE 105, MIAMI FL 33131
Leathem S Stearn	director	2306 BAY DRIVE, POMPANO BEACH FL 33062
Charles Luther Bretz	director	58 N. CHICAGO ST, 2ND FLOOR, JOLIET IL 60432
Bhupendra Kumar Modi	director	6 MARINA BOULEVARD, #63-18, THE SALE @ MARINA BAY U0 018985
Gurvinder Pal Singh	director	E - 128, FIRST FLOOR, GREATER KAILASH - II, NEW DELHI K7 110048
John F Chiste	director
Ryan C Likes	officer: Chief Operating Officer	1116 MEADOWBROOK AVE., LOS ANGELES CA 90019
Greyt Ventures, Llc	10 percent owner	GREYT VENTURES, LLC, 20533 BISCAYNE BOULEVARD, SUITE 648, AVENTURA FL 33180
Wendy Grey	10 percent owner	GREYT VENTURES, LLC, 20533 BISCAYNE BOULEVARD, SUITE 648, AVENTURA FL 33180
Ian T Bothwell	10 percent owner, officer: Chief Financial Officer	77 530 ENFIELD LANE, BLDG D, PALM DESERT CA 92211
Albert Mitrani	director, officer: Chief Executive Officer	4045 SHERIDAN AVE., SUITE 239, MIAMI BEACH FL 33140